Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.7148
+0.1261 (21.42%)
At close: May 12, 2025, 4:00 PM
0.7400
+0.0252 (3.53%)
After-hours: May 12, 2025, 7:39 PM EDT
Nektar Therapeutics Stock Forecast
NKTR's stock price has decreased by -59.39% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 4.92, with a low estimate of 2.00 and a high estimate of 7.00. The average target predicts an increase of 588.30% from the current stock price of 0.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 11, 2025.
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 3 | 3 | 4 | 4 |
| Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $1 → $2 | Hold → Strong Buy | Upgrades | $1 → $2 | +179.80% | Apr 11, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +739.40% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +809.35% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +809.35% | Feb 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +809.35% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
74.43M
from 98.43M
Decreased by -24.38%
Revenue Next Year
64.38M
from 74.43M
Decreased by -13.50%
EPS This Year
-0.67
from -0.58
EPS Next Year
-0.82
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 136.6M | 139.4M | 138.9M | ||
| Avg | 74.4M | 64.4M | 69.2M | ||
| Low | 44.7M | 23.5M | 7.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 38.8% | 87.3% | 115.8% | ||
| Avg | -24.4% | -13.5% | 7.5% | ||
| Low | -54.5% | -68.4% | -87.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.39 | -0.66 | -0.48 | ||
| Avg | -0.67 | -0.82 | -0.91 | ||
| Low | -0.77 | -1.21 | -1.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.